English

PHARMION CORP

EDGAR

Annual report (10-K) · filed 2008-02-29

18 filing records in this dataset, filed from 2003-12-19 to 2008-02-29. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

71.5 million USD

2007-12-31 · USD

Exact inputs and evidence

Revenue: 267300000 USD Source
Revenue: 195834000 USD Source

Operating margin

-43.61%

2007-12-31 · %

Exact inputs and evidence

Operating Income: -69248000 USD Source
Operating Income: -38080000 USD Source
Revenue: 267300000 USD Source
Revenue: 195834000 USD Source

Operating cash flow

-12.6 million USD

2007-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -23525000 USD Source
Operating Cash Flow: -10893000 USD Source

Free cash flow

-14 million USD

2007-12-31 · USD

Exact inputs and evidence

Operating Cash Flow: -23525000 USD Source
Operating Cash Flow: -10893000 USD Source
Capital Expenditure: 6736000 USD Source
Capital Expenditure: 5411000 USD Source

Cash and cash equivalents: 179 million USD 2007-12-31 Source
Exact value

178878000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

267 million USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Revenue: 62681000 USD · 2007-01-01 – 2007-03-31 Source
Revenue: 65838000 USD · 2007-04-01 – 2007-06-30 Source
Revenue: 67315000 USD · 2007-07-01 – 2007-09-30 Source
Revenue: 267300000 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 195834000 USD · 2007-01-01 – 2007-09-30 Source

Net income

-63.9 million USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Net income: -5656000 USD · 2007-01-01 – 2007-03-31 Source
Net income: -9288000 USD · 2007-04-01 – 2007-06-30 Source
Net income: -21440000 USD · 2007-07-01 – 2007-09-30 Source
Net income: -63860000 USD · 2007-01-01 – 2007-12-31 Source
Net income: -36384000 USD · 2007-01-01 – 2007-09-30 Source

Operating cash flow

-23.5 million USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Operating cash flow: -2475000 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -4728000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -2475000 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -10893000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -4728000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -23525000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -10893000 USD · 2007-01-01 – 2007-09-30 Source

Capital expenditure

6.74 million USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Capital expenditure: 1556000 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 3284000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 1556000 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 5411000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 3284000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 6736000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 5411000 USD · 2007-01-01 – 2007-09-30 Source

Free cash flow

-30.3 million USD

2007-01-01 – 2007-12-31

Exact inputs and evidence

Operating cash flow: -2475000 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -4728000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -2475000 USD · 2007-01-01 – 2007-03-31 Source
Operating cash flow: -10893000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: -4728000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: -23525000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: -10893000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 1556000 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 3284000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 1556000 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 5411000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 3284000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 6736000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 5411000 USD · 2007-01-01 – 2007-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-02-29.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2007-12-31
Operating income: 7 of 11 periods available· newest 2007-12-31
Net income: 7 of 11 periods available· newest 2007-12-31
Operating cash flow: 7 of 11 periods available· newest 2007-12-31
Capital expenditure: 7 of 11 periods available· newest 2007-12-31
Total assets: 6 of 11 periods available· newest 2007-12-31
Total liabilities: 6 of 11 periods available· newest 2007-12-31
Current assets: 6 of 11 periods available· newest 2007-12-31
Current liabilities: 6 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+12%

Prior period

USD 238.65 million

2006-01-01 – 2006-12-31
Current period

USD 267.3 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

267300000 − 238646000 = 28654000 USD

238646000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
267300000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Year-over-year change in Revenue: 28654000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 267300000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#22856 Input fundies:Revenue: 238646000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#22856
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 27.15 million

Prior period

−USD 91.01 million

2006-01-01 – 2006-12-31
Current period

−USD 63.86 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-63860000 − -91012000 = 27152000 USD

-91012000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-63860000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Year-over-year change in Net income: 27152000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -63860000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#27775 Input fundies:NetIncome: -91012000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#27775
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 82.17 million

Prior period

−USD 105.69 million

2006-01-01 – 2006-12-31
Current period

−USD 23.53 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-23525000 − -105692000 = 82167000 USD

-105692000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-23525000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Year-over-year change in Operating cash flow: 82167000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -23525000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377 Input fundies:OperatingCashFlow: -105692000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+172.4%

Prior period

USD 2.47 million

2006-01-01 – 2006-12-31
Current period

USD 6.74 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

6736000 − 2473000 = 4263000 USD

2473000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
6736000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Year-over-year change in Capital expenditure: 4263000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 6736000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463 Input fundies:CapitalExpenditure: 2473000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 267.3 million 100% of revenue
Operating costs Derived USD 336.55 million 126% of revenue
Operating income −USD 69.25 million −26% of revenue
Tax, interest and other Derived −USD 5.39 million −2% of revenue
Net income −USD 63.86 million −24% of revenue

Cash

Operating cash flow −USD 23.53 million −8.8% of revenue
Capital expenditure USD 6.74 million 2.5% of revenue
Free cash flow Derived −USD 30.26 million −11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Not shown: operating income or net income is not reported.
2002 Operating loss: operating costs were 854% of revenue.
2003 Operating loss: operating costs were 290% of revenue.
2004 Operating loss: operating costs were 109% of revenue.
2005 98%
2006 Operating loss: operating costs were 138% of revenue.
2007 Operating loss: operating costs were 126% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	0	14331895 Derived	-14331895	-621664 Derived	-13710231	-11990404 Derived	Source 2001-01-01 – 2001-12-31: 0 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -14331895 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -13710231 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -11008747 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 981657 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	4735354	40436645 Derived	-35701291	-1004435 Derived	-34696856	-37985354 Derived	Source 2002-01-01 – 2002-12-31: 4735354 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -35701291 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -34696856 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -35080685 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 2904669 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	25539248	74158287 Derived	-48619039	1439863 Derived	-50058902	-50171346 Derived	Source 2003-01-01 – 2003-12-31: 25539248 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -48619039 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -50058902 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -47702661 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 2468685 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	130171000	142270000 Derived	-12099000	5438000 Derived	-17537000	-7228000 Derived	Source 2004-01-01 – 2004-12-31: 130171000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -12099000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -17537000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -6063000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 1165000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	221244000	216655000 Derived	4589000	2320000 Derived	2269000	20727000 Derived	Source 2005-01-01 – 2005-12-31: 221244000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 4589000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 2269000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 25947000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 5220000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	238646000	328810000 Derived	-90164000	848000 Derived	-91012000	-108165000 Derived	Source 2006-01-01 – 2006-12-31: 238646000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -90164000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -91012000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -105692000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 2473000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	267300000	336548000 Derived	-69248000	-5388000 Derived	-63860000	-30261000 Derived	Source 2007-01-01 – 2007-12-31: 267300000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -69248000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -63860000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -23525000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 6736000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 267.3M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	0	Revenue: 0 Open source
20022002-12-31	Revenue	4735354	Revenue: 4735354 Open source
20032003-12-31	Revenue	25539248	Revenue: 25539248 Open source
20042004-12-31	Revenue	130171000	Revenue: 130171000 Open source
20052005-12-31	Revenue	221244000	Revenue: 221244000 Open source
20062006-12-31	Revenue	238646000	Revenue: 238646000 Open source
20072007-12-31	Revenue	267300000	Revenue: 267300000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

12% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 4735354 Open source Revenue: 0 Open source
20032003-12-31	Year over year	439.3%	Revenue: 25539248 Open source Revenue: 4735354 Open source
20042004-12-31	Year over year	409.7%	Revenue: 130171000 Open source Revenue: 25539248 Open source
20052005-12-31	Year over year	70%	Revenue: 221244000 Open source Revenue: 130171000 Open source
20062006-12-31	Year over year	7.9%	Revenue: 238646000 Open source Revenue: 221244000 Open source
20072007-12-31	Year over year	12%	Revenue: 267300000 Open source Revenue: 238646000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -25.9% 2007

Net margin -23.9% 2007

Free cash flow margin -11.3% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Operating margin	Not reported	Operating Income: -14331895 Open source Revenue: 0 Open source
20022002-12-31	Operating margin	-753.9%	Operating Income: -35701291 Open source Revenue: 4735354 Open source
20032003-12-31	Operating margin	-190.4%	Operating Income: -48619039 Open source Revenue: 25539248 Open source
20042004-12-31	Operating margin	-9.3%	Operating Income: -12099000 Open source Revenue: 130171000 Open source
20052005-12-31	Operating margin	2.1%	Operating Income: 4589000 Open source Revenue: 221244000 Open source
20062006-12-31	Operating margin	-37.8%	Operating Income: -90164000 Open source Revenue: 238646000 Open source
20072007-12-31	Operating margin	-25.9%	Operating Income: -69248000 Open source Revenue: 267300000 Open source
20012001-12-31	Net margin	Not reported	Net Income: -13710231 Open source Revenue: 0 Open source
20022002-12-31	Net margin	-732.7%	Net Income: -34696856 Open source Revenue: 4735354 Open source
20032003-12-31	Net margin	-196%	Net Income: -50058902 Open source Revenue: 25539248 Open source
20042004-12-31	Net margin	-13.5%	Net Income: -17537000 Open source Revenue: 130171000 Open source
20052005-12-31	Net margin	1%	Net Income: 2269000 Open source Revenue: 221244000 Open source
20062006-12-31	Net margin	-38.1%	Net Income: -91012000 Open source Revenue: 238646000 Open source
20072007-12-31	Net margin	-23.9%	Net Income: -63860000 Open source Revenue: 267300000 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -11008747 Open source Capital Expenditure: 981657 Open source
20022002-12-31	Free cash flow margin	-802.2%	Revenue: 4735354 Open source Operating Cash Flow: -35080685 Open source Capital Expenditure: 2904669 Open source
20032003-12-31	Free cash flow margin	-196.4%	Revenue: 25539248 Open source Operating Cash Flow: -47702661 Open source Capital Expenditure: 2468685 Open source
20042004-12-31	Free cash flow margin	-5.6%	Revenue: 130171000 Open source Operating Cash Flow: -6063000 Open source Capital Expenditure: 1165000 Open source
20052005-12-31	Free cash flow margin	9.4%	Revenue: 221244000 Open source Operating Cash Flow: 25947000 Open source Capital Expenditure: 5220000 Open source
20062006-12-31	Free cash flow margin	-45.3%	Revenue: 238646000 Open source Operating Cash Flow: -105692000 Open source Capital Expenditure: 2473000 Open source
20072007-12-31	Free cash flow margin	-11.3%	Revenue: 267300000 Open source Operating Cash Flow: -23525000 Open source Capital Expenditure: 6736000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -23.5M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	-11008747	Operating Cash Flow: -11008747 Open source
20022002-12-31	Operating cash flow	-35080685	Operating Cash Flow: -35080685 Open source
20032003-12-31	Operating cash flow	-47702661	Operating Cash Flow: -47702661 Open source
20042004-12-31	Operating cash flow	-6063000	Operating Cash Flow: -6063000 Open source
20052005-12-31	Operating cash flow	25947000	Operating Cash Flow: 25947000 Open source
20062006-12-31	Operating cash flow	-105692000	Operating Cash Flow: -105692000 Open source
20072007-12-31	Operating cash flow	-23525000	Operating Cash Flow: -23525000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -30.3M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	-11990404	Operating Cash Flow: -11008747 Open source Capital Expenditure: 981657 Open source
20022002-12-31	Free cash flow	-37985354	Operating Cash Flow: -35080685 Open source Capital Expenditure: 2904669 Open source
20032003-12-31	Free cash flow	-50171346	Operating Cash Flow: -47702661 Open source Capital Expenditure: 2468685 Open source
20042004-12-31	Free cash flow	-7228000	Operating Cash Flow: -6063000 Open source Capital Expenditure: 1165000 Open source
20052005-12-31	Free cash flow	20727000	Operating Cash Flow: 25947000 Open source Capital Expenditure: 5220000 Open source
20062006-12-31	Free cash flow	-108165000	Operating Cash Flow: -105692000 Open source Capital Expenditure: 2473000 Open source
20072007-12-31	Free cash flow	-30261000	Operating Cash Flow: -23525000 Open source Capital Expenditure: 6736000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

19% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Liabilities / assets	Not reported	No source recorded
20022002-12-31	Liabilities / assets	8.8%	Total Liabilities: 7076040 Open source Total Assets: 80846635 Open source
20032003-12-31	Liabilities / assets	27.9%	Total Liabilities: 40558852 Open source Total Assets: 145472587 Open source
20042004-12-31	Liabilities / assets	14.4%	Total Liabilities: 59277771 Open source Total Assets: 411230472 Open source
20052005-12-31	Liabilities / assets	19.9%	Total Liabilities: 86006000 Open source Total Assets: 432630000 Open source
20062006-12-31	Liabilities / assets	16.4%	Total Liabilities: 53650000 Open source Total Assets: 326732000 Open source
20072007-12-31	Liabilities / assets	19%	Total Liabilities: 84379000 Open source Total Assets: 443324000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Current assets / current liabilities	Not reported	No source recorded
20022002-12-31	Current assets / current liabilities	9.84×	Current Assets: 67777391 Open source Current Liabilities: 6885925 Open source
20032003-12-31	Current assets / current liabilities	5.54×	Current Assets: 105579321 Open source Current Liabilities: 19040512 Open source
20042004-12-31	Current assets / current liabilities	5.21×	Current Assets: 288819824 Open source Current Liabilities: 55454222 Open source
20052005-12-31	Current assets / current liabilities	3.75×	Current Assets: 308890000 Open source Current Liabilities: 82269000 Open source
20062006-12-31	Current assets / current liabilities	4.06×	Current Assets: 202968000 Open source Current Liabilities: 49971000 Open source
20072007-12-31	Current assets / current liabilities	4×	Current Assets: 322792000 Open source Current Liabilities: 80644000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 13.71 million Exact value Exact value: -13710231 USD 2001-01-01 – 2001-12-31: -13710231 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMION CORP · 2001-12-31 PHARMION CORP (edgar:1203866) Net Income: -13710231 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13710231 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-04-004144.txt#12968 The citation records this snapshot. The page link may show a newer release later.	−USD 11.01 million Exact value Exact value: -11008747 USD 2001-01-01 – 2001-12-31: -11008747 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMION CORP · 2001-12-31 PHARMION CORP (edgar:1203866) Operating Cash Flow: -11008747 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11008747 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-04-004144.txt#13277 The citation records this snapshot. The page link may show a newer release later.	USD 981,657 Exact value Exact value: 981657 USD 2001-01-01 – 2001-12-31: 981657 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMION CORP · 2001-12-31 PHARMION CORP (edgar:1203866) Capital Expenditure: 981657 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 981657 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-04-004144.txt#13317 The citation records this snapshot. The page link may show a newer release later.	−USD 11.99 million Calculation and evidence -11008747 − 981657 USD Exact free cash flow: -11990404 USD 2001-01-01 – 2001-12-31: -11008747 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 981657 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMION CORP · 2001-12-31 PHARMION CORP (edgar:1203866) Free cash flow: -11990404 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11008747 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-04-004144.txt#13277 Input fundies:CapitalExpenditure: 981657 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-04-004144.txt#13317 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 34.7 million Exact value Exact value: -34696856 USD 2002-01-01 – 2002-12-31: -34696856 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMION CORP · 2002-12-31 PHARMION CORP (edgar:1203866) Net Income: -34696856 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34696856 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-05-005176.txt#13833 The citation records this snapshot. The page link may show a newer release later.	−USD 35.08 million Exact value Exact value: -35080685 USD 2002-01-01 – 2002-12-31: -35080685 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMION CORP · 2002-12-31 PHARMION CORP (edgar:1203866) Operating Cash Flow: -35080685 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -35080685 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-05-005176.txt#14104 The citation records this snapshot. The page link may show a newer release later.	USD 2.9 million Exact value Exact value: 2904669 USD 2002-01-01 – 2002-12-31: 2904669 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMION CORP · 2002-12-31 PHARMION CORP (edgar:1203866) Capital Expenditure: 2904669 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2904669 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-05-005176.txt#14142 The citation records this snapshot. The page link may show a newer release later.	−USD 37.99 million Calculation and evidence -35080685 − 2904669 USD Exact free cash flow: -37985354 USD 2002-01-01 – 2002-12-31: -35080685 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 2904669 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMION CORP · 2002-12-31 PHARMION CORP (edgar:1203866) Free cash flow: -37985354 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35080685 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-05-005176.txt#14104 Input fundies:CapitalExpenditure: 2904669 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-05-005176.txt#14142 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 50.06 million Exact value Exact value: -50058902 USD 2003-01-01 – 2003-12-31: -50058902 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMION CORP · 2003-12-31 PHARMION CORP (edgar:1203866) Net Income: -50058902 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -50058902 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-06-000180.txt#15350 The citation records this snapshot. The page link may show a newer release later.	−USD 47.7 million Exact value Exact value: -47702661 USD 2003-01-01 – 2003-12-31: -47702661 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMION CORP · 2003-12-31 PHARMION CORP (edgar:1203866) Operating Cash Flow: -47702661 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -47702661 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-06-000180.txt#15643 The citation records this snapshot. The page link may show a newer release later.	USD 2.47 million Exact value Exact value: 2468685 USD 2003-01-01 – 2003-12-31: 2468685 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMION CORP · 2003-12-31 PHARMION CORP (edgar:1203866) Capital Expenditure: 2468685 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2468685 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-06-000180.txt#15681 The citation records this snapshot. The page link may show a newer release later.	−USD 50.17 million Calculation and evidence -47702661 − 2468685 USD Exact free cash flow: -50171346 USD 2003-01-01 – 2003-12-31: -47702661 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 2468685 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMION CORP · 2003-12-31 PHARMION CORP (edgar:1203866) Free cash flow: -50171346 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -47702661 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-06-000180.txt#15643 Input fundies:CapitalExpenditure: 2468685 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-06-000180.txt#15681 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 17.54 million Exact value Exact value: -17537000 USD 2004-01-01 – 2004-12-31: -17537000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMION CORP · 2004-12-31 PHARMION CORP (edgar:1203866) Net Income: -17537000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -17537000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-07-005675.txt#24678 The citation records this snapshot. The page link may show a newer release later.	−USD 6.06 million Exact value Exact value: -6063000 USD 2004-01-01 – 2004-12-31: -6063000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMION CORP · 2004-12-31 PHARMION CORP (edgar:1203866) Operating Cash Flow: -6063000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6063000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-07-005675.txt#25296 The citation records this snapshot. The page link may show a newer release later.	USD 1.17 million Exact value Exact value: 1165000 USD 2004-01-01 – 2004-12-31: 1165000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMION CORP · 2004-12-31 PHARMION CORP (edgar:1203866) Capital Expenditure: 1165000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1165000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-07-005675.txt#25384 The citation records this snapshot. The page link may show a newer release later.	−USD 7.23 million Calculation and evidence -6063000 − 1165000 USD Exact free cash flow: -7228000 USD 2004-01-01 – 2004-12-31: -6063000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 1165000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMION CORP · 2004-12-31 PHARMION CORP (edgar:1203866) Free cash flow: -7228000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6063000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-07-005675.txt#25296 Input fundies:CapitalExpenditure: 1165000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0000950134-07-005675.txt#25384 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 2.27 million Exact value Exact value: 2269000 USD 2005-01-01 – 2005-12-31: 2269000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMION CORP · 2005-12-31 PHARMION CORP (edgar:1203866) Net Income: 2269000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2269000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#27775 The citation records this snapshot. The page link may show a newer release later.	USD 25.95 million Exact value Exact value: 25947000 USD 2005-01-01 – 2005-12-31: 25947000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMION CORP · 2005-12-31 PHARMION CORP (edgar:1203866) Operating Cash Flow: 25947000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 25947000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377 The citation records this snapshot. The page link may show a newer release later.	USD 5.22 million Exact value Exact value: 5220000 USD 2005-01-01 – 2005-12-31: 5220000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMION CORP · 2005-12-31 PHARMION CORP (edgar:1203866) Capital Expenditure: 5220000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5220000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463 The citation records this snapshot. The page link may show a newer release later.	USD 20.73 million Calculation and evidence 25947000 − 5220000 USD Exact free cash flow: 20727000 USD 2005-01-01 – 2005-12-31: 25947000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 5220000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMION CORP · 2005-12-31 PHARMION CORP (edgar:1203866) Free cash flow: 20727000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25947000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377 Input fundies:CapitalExpenditure: 5220000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 91.01 million Exact value Exact value: -91012000 USD 2006-01-01 – 2006-12-31: -91012000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMION CORP · 2006-12-31 PHARMION CORP (edgar:1203866) Net Income: -91012000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -91012000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#27775 The citation records this snapshot. The page link may show a newer release later.	−USD 105.69 million Exact value Exact value: -105692000 USD 2006-01-01 – 2006-12-31: -105692000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMION CORP · 2006-12-31 PHARMION CORP (edgar:1203866) Operating Cash Flow: -105692000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -105692000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377 The citation records this snapshot. The page link may show a newer release later.	USD 2.47 million Exact value Exact value: 2473000 USD 2006-01-01 – 2006-12-31: 2473000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMION CORP · 2006-12-31 PHARMION CORP (edgar:1203866) Capital Expenditure: 2473000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2473000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463 The citation records this snapshot. The page link may show a newer release later.	−USD 108.17 million Calculation and evidence -105692000 − 2473000 USD Exact free cash flow: -108165000 USD 2006-01-01 – 2006-12-31: -105692000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 2473000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMION CORP · 2006-12-31 PHARMION CORP (edgar:1203866) Free cash flow: -108165000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -105692000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377 Input fundies:CapitalExpenditure: 2473000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 63.86 million Exact value Exact value: -63860000 USD 2007-01-01 – 2007-12-31: -63860000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Net Income: -63860000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -63860000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#27775 The citation records this snapshot. The page link may show a newer release later.	−USD 23.53 million Exact value Exact value: -23525000 USD 2007-01-01 – 2007-12-31: -23525000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Operating Cash Flow: -23525000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23525000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377 The citation records this snapshot. The page link may show a newer release later.	USD 6.74 million Exact value Exact value: 6736000 USD 2007-01-01 – 2007-12-31: 6736000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Capital Expenditure: 6736000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6736000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463 The citation records this snapshot. The page link may show a newer release later.	−USD 30.26 million Calculation and evidence -23525000 − 6736000 USD Exact free cash flow: -30261000 USD 2007-01-01 – 2007-12-31: -23525000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 6736000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PHARMION CORP · 2007-12-31 PHARMION CORP (edgar:1203866) Free cash flow: -30261000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-04T14:28:33Z Snapshot: 199abc71de0a9d9c4b8d636b6853a368f0aea8ef00ea7b7bbc8fed66687bca0c Dimensions: Consolidated View: https://fundies.io/companies/edgar/1203866?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23525000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28377 Input fundies:CapitalExpenditure: 6736000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1203866/0001035704-08-000097.txt#28463 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

18 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001203866, 1203866, edgar:1203866

PHARMION CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation